These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38115987)

  • 1. Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability [Retraction].
    Int J Nanomedicine; 2023; 18():7711-7712. PubMed ID: 38115987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability.
    Rahim H; Sadiq A; Ullah R; Bari A; Amin F; Farooq U; Ullah Jan N; Mahmood HM
    Int J Nanomedicine; 2020; 15():8999-9009. PubMed ID: 33235448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Retraction].
    Int J Nanomedicine; 2022; 17():5779-5780. PubMed ID: 36466786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Solvent-Anti-solvent Method of Nanosuspension for Enhanced Oral Bioavailability of Lovastatin.
    Patil AS; Hegde R; Gadad AP; Dandagi PM; Masareddy R; Bolmal U
    Turk J Pharm Sci; 2021 Oct; 18(5):541-549. PubMed ID: 34708645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality by design-based optimization of formulation and process parameters for berberine nanosuspension for enhancing its dissolution rate, bioavailability, and cardioprotective activity.
    Alsabeelah N; Kumar V
    J Food Biochem; 2022 Oct; 46(10):e14361. PubMed ID: 35929374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
    Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
    Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Performance Variables of Exemestane Nanosuspension Using Box-Behnken Design to Improve Dissolution and Oral Bioavailability.
    Parmar K; Shah J
    Curr Drug Deliv; 2021; 18(8):1148-1161. PubMed ID: 33438540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Nanosuspension of
    Jahan N; Kousar F; Rahman KU; Touqeer SI; Abbas N
    J Funct Biomater; 2023 Aug; 14(8):. PubMed ID: 37623677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation.
    Nakarani M; Misra AK; Patel JK; Vaghani SS
    Daru; 2010; 18(2):84-90. PubMed ID: 22615599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation.
    Liu Y; Li Y; Xu P; Shen Y; Tang B; Wang Q
    Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
    Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL
    Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of chondroitin sulphate tablets of aceclofenac for colon targeted drug delivery.
    Ramasamy T; Subbaih Khandasamy U; Shanmugam S; Ruttala H
    Iran J Pharm Res; 2012; 11(2):465-79. PubMed ID: 24250470
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Shariare MH; Altamimi MA; Marzan AL; Tabassum R; Jahan B; Reza HM; Rahman M; Ahsan GU; Kazi M
    Saudi Pharm J; 2019 Jan; 27(1):96-105. PubMed ID: 30662312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Oral Bioavailability of Piperine from an Optimized Piper nigrum Nanosuspension.
    Zafar F; Jahan N; ; Bhatti HN
    Planta Med; 2019 Feb; 85(3):249-257. PubMed ID: 30357764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
    Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
    Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor.
    Na YG; Pham TMA; Byeon JJ; Kim MK; Han MG; Baek JS; Lee HK; Cho CW
    Int J Pharm; 2020 May; 581():119287. PubMed ID: 32243963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development and optimization of bilayer tablets of aceclofenac.
    Dey S; Mahanti B; Khila S; Mazumder B; Gupta SD
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1041-50. PubMed ID: 22788786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement.
    Mori D; Makwana J; Parmar R; Patel K; Chavda J
    Pak J Pharm Sci; 2016 Nov; 29(6):1927-1936. PubMed ID: 28375107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.